What is it about?
The claim is made that medical statisticians should pay more attention to the measures that are defined to judge the effect of treatments rather than leaving this activity entirely as the province of their physician colleagues.
Featured Image
Why is it important?
Many habits of measurement in clinical trials, for example dichotomising continuous measurements or classifying patients as responders or non-responders are not only inefficient but potentially misleading.
Read the Original
This page is a summary of: Measurement in clinical trials: A neglected issue for statisticians?, Statistics in Medicine, May 2009, Wiley,
DOI: 10.1002/sim.3603.
You can read the full text:
Contributors
The following have contributed to this page
